At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
JUNS Jupiter Neurosciences
Trading 09-18 13:02:36 EDT
3.14
+0.13
+4.32%
High3.14
Low3.00
Vol5.24K
Open3.05
D1 Closing3.01
Amplitude4.65%
Mkt Cap4.14M
Tradable Cap3.45M
Total Shares1.32M
T/O16.01K
T/O Rate0.48%
Tradable Shares1.10M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Jupiter Neurosciences Lowers Stockholder Meeting Quorum Requirement to One-Third of Voting Power
Jupiter Neurosciences, Inc. was incorporated in Delaware in January 2016. The company is a clinical-stage R&D company focused on developing treatments for neuroinflammation using its proprietary resveratrol formulation, JOTROL. Its primary therapeutic target is Parkinson's disease, for which it plans to conduct a Phase IIa clinical trial, and it has launched a consumer-facing product line called Nugevia focused on longevity and wellness.